New York Attorney General Files Insider Trading Lawsuit Against Former Emergent BioSolutions CEO Robert Kramer

New York Attorney General Letitia James filed a lawsuit against Robert Kramer for trading on undisclosed vaccine contamination news. He profited by millions.

洞察:
New York Attorney General Letitia James letitia jamesfiled a civil insider trading lawsuit on January 15, 2026, against Robert Kramer robert kramer, the former chief executive officer of Emergent BioSolutions Inc. . The lawsuit, filed in a New York state court in Manhattan, alleges that Robert Kramerviolated the Martin Act, a state securities law, by selling company stock while aware of significant contamination problems at the Baltimore vaccine manufacturing plant.
Robert Kramer, President and Chief Executive Officer of Emergent BioSolutions, speaks via videoconference during a House Select Subcommittee on the Coronavirus Crisis hearing on Capitol Hill in Washington, U.S., May 19, 2021. Stefani Reynolds/Pool via REUTERS
Robert Kramer, President and Chief Executive Officer of Emergent BioSolutions, speaks via videoconference during a House Select Subcommittee on the Coronavirus Crisis hearing on Capitol Hill in Washington, U.S., May 19, 2021. Stefani Reynolds/Pool via REUTERS